Pain Therapeutics Inc. (PTIE)

1.08 -0.05 (-4.425%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 1.13

Price Open 1.12

Volume: 214,989

Avg Volume: 1.08M

Market Cap: 18.6M

P/E Ratio -0.92

52 Wk Range 0.809822-12.8



PTIE Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
11.46M
2.47M
0.46
21.52%

2018-09-28
11.46M
1.52M
1.88
13.23%

2018-09-14
11.46M
1.65M
0.72
14.41%

2018-08-31
11.46M
1.12M
0.53
9.78%




PTIE Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-07-26
Q2 2018
N/A
0.00 (0)
-0.36
0.00

2018-05-09
Q1 2018
N/A
0.00 (0)
-0.33
0.00

2018-04-24
Q1 2018
N/A
0.00 (0)
0.00
0.00

2018-02-16
Q4 2017
N/A
0.00 (0)
0.00
0.00

News

APTI, KODK among premarket gainers (2018-11-12 09:27 SeekingAlpha)

Apptio (NASDAQ: APTI ) +52% on going private by Vista Equity Partners for $38/share. More news on: Apptio, Eastman Kodak Co., Matinas Biopharma Holdings, Inc., Stocks on the move, , Top stock market news, Read more …

 


Statistics

Shares Outstanding: 17.22M

Top 15 Institution Percent: 6.00

Price To Sales: N/A

Price To Book: 0.97

Revenue: N/A

Gross Profit: N/A

Cash: 10.48M

Debt: N/A

Return On Assets: -49.97

Return On Equity: -52.95

Profit Margin: N/A

Price History

Beta: 1.74

50-day Moving Avg: 1.17

200-day Moving Avg: 4.73

YTD Change: -73.59

5-day Change: -9.24

1-month Change: -10.74

3-month Change: 4.85

6-month Change: -89.83

1-year Change: -72.24

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Pain Therapeutics Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.paintrials.com

Pain Therapeutics Inc is a biopharmaceutical company that develops novel drugs. The Company has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.